BARCLAYS PLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 92 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$62
-17.3%
36,745
-5.0%
0.00%
Q2 2023$75
-62.9%
38,662
-46.8%
0.00%
Q1 2023$202
+129.5%
72,675
+186.2%
0.00%
Q4 2022$88
-99.9%
25,395
+0.7%
0.00%
Q3 2022$64,000
+18.5%
25,225
+12.9%
0.00%
Q2 2022$54,000
-56.1%
22,347
-24.7%
0.00%
Q1 2022$123,000
-93.6%
29,675
-80.0%
0.00%
Q4 2021$1,908,000
+385.5%
148,416
+307.7%
0.00%
Q3 2021$393,000
+80.3%
36,405
+52.5%
0.00%
Q2 2021$218,000
-68.6%
23,866
-67.6%
0.00%
Q1 2021$694,000
+1726.3%
73,638
+654.3%
0.00%
Q4 2020$38,000
+2.7%
9,763
-29.4%
0.00%
Q3 2020$37,000
-66.1%
13,831
-15.6%
0.00%
Q2 2020$109,000
+127.1%
16,384
+98.3%
0.00%
Q1 2020$48,000
-78.7%
8,263
-67.2%
0.00%
Q4 2019$225,000
+100.9%
25,226
+93.1%
0.00%
Q3 2019$112,000
-38.1%
13,066
-19.6%
0.00%
Q2 2019$181,000
-32.0%
16,259
-18.7%
0.00%
Q1 2019$266,000
+297.0%
20,000
+359.3%
0.00%
Q4 2018$67,000
-52.8%
4,354
-56.5%
0.00%
Q3 2018$142,00010,0000.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders